These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22540979)

  • 1. Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders.
    Ting JT; Peça J; Feng G
    Annu Rev Neurosci; 2012; 35():49-71. PubMed ID: 22540979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular mechanism underlying the formation and maintenance of excitatory synapses].
    Kondo S; Okabe S
    Brain Nerve; 2011 Jan; 63(1):51-8. PubMed ID: 21228448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAPAP Scaffold Proteins: From Synaptic Function to Neuropsychiatric Disorders.
    Bai Y; Wang H; Li C
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synapse development in health and disease.
    Melom JE; Littleton JT
    Curr Opin Genet Dev; 2011 Jun; 21(3):256-61. PubMed ID: 21277192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shank postsynaptic scaffolding proteins in autism spectrum disorder: Mouse models and their dysfunctions in behaviors, synapses, and molecules.
    Jung S; Park M
    Pharmacol Res; 2022 Aug; 182():106340. PubMed ID: 35792298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the postsynaptic density in the pathology of the fragile X syndrome.
    Kindler S; Kreienkamp HJ
    Results Probl Cell Differ; 2012; 54():61-80. PubMed ID: 22009348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanisms underlying the regulation of synapse function and the molecular architecture of the postsynaptic density].
    Bito H; Nonaka M; Fuse T; Fujii H; Takemoto-Kimura S; Okuno H
    Tanpakushitsu Kakusan Koso; 2008 Mar; 53(4 Suppl):418-23. PubMed ID: 21089313
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.
    Soler J; Fañanás L; Parellada M; Krebs MO; Rouleau GA; Fatjó-Vilas M
    J Psychiatry Neurosci; 2018 Jul; 43(4):223-244. PubMed ID: 29947605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of postsynaptic density proteins: glutamate receptor subunits and scaffolding proteins.
    Shinohara Y
    Hippocampus; 2012 May; 22(5):942-53. PubMed ID: 21594948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations affecting synaptic levels of neurexin-1β in autism and mental retardation.
    Camacho-Garcia RJ; Planelles MI; Margalef M; Pecero ML; Martínez-Leal R; Aguilera F; Vilella E; Martinez-Mir A; Scholl FG
    Neurobiol Dis; 2012 Jul; 47(1):135-43. PubMed ID: 22504536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the cytoskeleton by Disrupted-in-schizophrenia 1 (DISC1).
    Wang Q; Brandon NJ
    Mol Cell Neurosci; 2011 Dec; 48(4):359-64. PubMed ID: 21757008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and cognitive windows into circuit mechanisms of psychiatric disease.
    Arguello PA; Gogos JA
    Trends Neurosci; 2012 Jan; 35(1):3-13. PubMed ID: 22177981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proline-rich synapse-associated protein-1 and 2 (ProSAP1/Shank2 and ProSAP2/Shank3)-scaffolding proteins are also present in postsynaptic specializations of the peripheral nervous system.
    Raab M; Boeckers TM; Neuhuber WL
    Neuroscience; 2010 Dec; 171(2):421-33. PubMed ID: 20800661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence imaging of synapse formation and remodeling.
    Okabe S
    Microscopy (Oxf); 2013 Feb; 62(1):51-62. PubMed ID: 23243097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of psychiatric disorders associated with human chromosome 18.
    Kamnasaran D
    Clin Invest Med; 2003 Dec; 26(6):285-302. PubMed ID: 14690303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gray area between synapse structure and function-Gray's synapse types I and II revisited.
    Klemann CJ; Roubos EW
    Synapse; 2011 Nov; 65(11):1222-30. PubMed ID: 21656572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models of psychiatric disease.
    Flint J; Shifman S
    Curr Opin Genet Dev; 2008 Jun; 18(3):235-40. PubMed ID: 18657615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic dysfunction in complex psychiatric disorders: from genetics to mechanisms.
    Wang X; Christian KM; Song H; Ming GL
    Genome Med; 2018 Jan; 10(1):9. PubMed ID: 29386063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current developments in genetics and their implications concerning the problems of social deviations].
    Shah SA
    Quad Criminol Clin; 1975; 17(2):173-226. PubMed ID: 1230825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitatory synaptic activity is associated with a rapid structural plasticity of inhibitory synapses on hippocampal CA1 pyramidal cells.
    Lushnikova I; Skibo G; Muller D; Nikonenko I
    Neuropharmacology; 2011 Apr; 60(5):757-64. PubMed ID: 21187106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.